WO2023195957 - A FILM COATED TABLET COMPRISING SELEXİPAG PROCESSED WITH WET GRANULATION

National phase entry:
Publication Number WO/2023/195957
Publication Date 12.10.2023
International Application No. PCT/TR2023/050306
International Filing Date 30.03.2023
Title **
[English] A FILM COATED TABLET COMPRISING SELEXİPAG PROCESSED WITH WET GRANULATION
[French] COMPRIMÉ PELLICULÉ COMPRENANT DU SELEXİPAG TRAITÉ PAR GRANULATION HUMIDE
Applicants **
SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
Inventors
SUNEL, Fatih
ATAK, Fadime Bilgehan
PEHLIVAN AKALIN, Nur
TUNC, Guldeniz
Priority Data
2022/005277   05.04.2022   TR
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
Translation

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting2016
EPO Filing, Examination, Granting9276
Japan Filing, Examination, Granting2104
South Korea Filing, Examination, Granting1880
USA Filing, Examination, Granting4740
MasterCard Visa
Total: 20,016

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Abstract[English] The present invention relates to a film coated tablet comprising selexipag or crystalline polymorph thereof and at least one pharmaceutically acceptable excipient, wherein the tablet is obtained by wet granulation with geometric dilution method.[French] La présente invention concerne un comprimé pelliculé comprenant du selexipag ou un polymorphe cristallin de celui-ci et au moins un excipient pharmaceutiquement acceptable, le comprimé étant obtenu par granulation humide avec un procédé de dilution géométrique.

Rejoining the server...